Cisplatin/Gemcitabine/Pembrolizumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen composed of cisplatin, gemcitabine, and pembrolizumab that may be used in the treatment of non-small cell lung cancer (NSCLC), biliary tract cancer and cancer of the nasopharynx.

**Synonyms:** - Cisplatin and Gemcitabine (GC) and Pembrolizumab - Cisplatin-Gemcitabine-Pembrolizumab - Cisplatin/Gemcitabine/Keytruda - Cisplatin/Gemcitabine/Pembrolizumab